M. Kovalainen

发表

Immobilization of protein-coated drug nanoparticles in nanofibrillar cellulose matrices--enhanced stability and release.

K. Järvinen, P. Laaksonen, M. Linder, 2011, Journal of controlled release : official journal of the Controlled Release Society.

Nanocrystal-based per-oral itraconazole delivery: superior in vitro dissolution enhancement versus Sporanox® is not realized in in vivo drug absorption.

K. Järvinen, S. Rönkkö, J. Hirvonen, 2014, Journal of controlled release : official journal of the Controlled Release Society.

Supersaturated Silica-Lipid Hybrid Oral Drug Delivery Systems: Balancing Drug Loading and In Vivo Performance

C. Prestidge, M. Kovalainen, N. Thomas, 2018, The Journal of Pharmacology and Experimental Therapeutics.

Supersaturated silica-lipid hybrid (super-SLH) oral drug delivery systems: Balancing drug loading and in vivo performance

C. Prestidge, M. Kovalainen, N. Thomas, 2018 .

Fat mass- and obesity-associated gene Fto affects the dietary response in mouse white adipose tissue

M. Järvelin, S. Sebert, M. Savolainen, 2015, Scientific Reports.

Development of porous silicon nanocarriers for parenteral peptide delivery.

K. Järvinen, K. Herzig, J. Salonen, 2013, Molecular pharmaceutics.

Inorganic mesoporous particles for controlled α-linolenic acid delivery to stimulate GLP-1 secretion in vitro.

K. Herzig, V. Lehto, J. Walkowiak, 2019, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Systematic in vitro and in vivo study on porous silicon to improve the oral bioavailability of celecoxib.

J. Leppänen, H. Santos, K. Järvinen, 2015, Biomaterials.

Contrasting Anti-obesity Effects of Smectite Clays and Mesoporous Silica in Sprague-Dawley Rats.

C. Prestidge, P. Joyce, Tahnee J Dening, 2020, ACS applied bio materials.

Nanostructured clay particles supplement orlistat action in inhibiting lipid digestion: An in vitro evaluation for the treatment of obesity.

C. Prestidge, P. Joyce, Hanna Gustafsson, 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Nanocarriers and the delivered drug: effect interference due to intravenous administration.

K. Järvinen, K. Herzig, A. Närvänen, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Effect of surface chemistry of porous silicon microparticles on glucagon-like peptide-1 (GLP-1) loading, release and biological activity.

K. Järvinen, K. Herzig, V. Lehto, 2013, International journal of pharmaceutics.

Neuropeptide Y in the noradrenergic neurones induces obesity and inhibits sympathetic tone in mice

J. Määttä, J. Määttä, K. Herzig, 2015, Acta physiologica.

Distinct Effects of Calorie Restriction and Resveratrol on Diet-Induced Obesity and Fatty Liver Formation

E. Mervaala, K. Herzig, P. Finckenberg, 2011, Journal of nutrition and metabolism.

Spray Dried Smectite Clay Particles as a Novel Treatment against Obesity

C. Prestidge, P. Joyce, Hanna Gustafsson, 2018, Pharmaceutical Research.

Spray Dried Smectite Clay Particles as a Novel Treatment against Obesity

C. Prestidge, P. Joyce, Hanna Gustafsson, 2018, Pharmaceutical Research.

The effects of group and single housing and automated animal monitoring on urinary corticosterone levels in male C57BL/6 mice

J. Leppäluoto, K. Herzig, M. Kovalainen, 2016, Physiological reports.

Novel Delivery Systems for Improving the Clinical Use of Peptides

U. Pesonen, K. Järvinen, K. Herzig, 2015, Pharmacological Reviews.

Effect of isotonic solutions and peptide adsorption on zeta potential of porous silicon nanoparticle drug delivery formulations.

Vesa-Pekka Lehto, Jarno Salonen, Ermei Mäkilä, 2012, International journal of pharmaceutics.

Mesoporous Silicon (PSi) for Sustained Peptide Delivery: Effect of PSi Microparticle Surface Chemistry on Peptide YY3-36 Release

K. Järvinen, K. Herzig, J. Salonen, 2012, Pharmaceutical Research.

Biodegradation of inorganic drug delivery systems in subcutaneous conditions

K. Herzig, P. Perämäki, V. Lehto, 2018, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Neuromedin peptides—Potential for anti-obesity drug candidates?

M. Kovalainen, 2017, Peptides.

Pre-proofs Inorganic mesoporous particles for controlled α-linolenic acid delivery to stimulate GLP-1 secretion in vitro

V. Lehto, M. Kovalainen, J. Riikonen, 2019 .

Photocrosslinked poly(ester anhydride)s for peptide delivery: Effect of oligomer hydrophobicity on PYY3-36 delivery.

J. Seppälä, K. Järvinen, K. Herzig, 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.